Today I discuss spike protein detoxification, taking advantage of cancers' metabolic weakness, my indexed "vaccine" injuries 1000 articles library which lawyers will love, and welcome nurses and doctors to make informed and ethical decisions.

ãããã©ã¼æ ªå¼ä¼ç¤¾ï¼æ¬ç¤¾ï¼æ±äº¬é½å代ç°åºã社é·ï¼å¤§ä¸ä¸æï¼ã¯ãæç¶å¹æããã¯ã¼ã¢ãããããããã»ã¢ã ããºã¼ã«ã¸ã§ããããå ¨å½ã®ãã©ãã°ã¹ãã¢ããã¼ã ã»ã³ã¿ã¼ãã¹ã¼ãã¼ãªã©ã§é 次çºå£²ãããã¾ãã ãããã»ã¢ã ããºã¼ã«ã¸ã§ãããã¯ãå·£ãä½ããããªå ´æã«ãããããã¹ãã¬ã¼ãã¦ããã°ã4ãµæâ»1ããããå¯ãã¤ãã¾ãããããã«é广®ºè«æåã¨ç¾½ã°ãã忢æåãè¡å忢æåãå±éºãªããã®åãããã°ããæ¢ãã¦é§é¤ãã¾ãã â»1 å·£ä½ã黿¢å¹æ ï¼è£½åæ¦è¦ï¼ â4ãµæâ»1å·£ä½ã黿¢ï¼å·£ãã¨éæ²»ï¼ å·£ãä½ããããªå ´æã«ãããããã¹ãã¬ã¼ãã¦ããã°ã4ãµæâ»1ããããå¯ãã¤ãã¾ããã å·£ã«æ»ã£ã¦ãããããæ°ãã«ç¾½åããããã«ã广ãçºæ®ããå·£ãã¨éæ²»ãã¾ãã â»1 å·£ä½ã黿¢å¹æ âåããæ¢ãã¦éå¹éæ²»ï¼ é广®ºè«æåã¨ç¾½ã°ãã忢æåãè¡å忢æåããå±éºãªããã®åãããã°ããæ¢ãã¦æ´ããéãä¸ããããã£
æ°åã³ããã¦ã¤ã«ã¹ã®ã¯ã¯ãã³ãæ¥ç¨®ãããã¨ã«äº¡ããªã£ã人ã®éºæã§ã¤ããå£ä½ããåçå´åçã§ä¼è¦ããäºé²æ¥ç¨®æ³ã«åºã¥ããå¥åº·è¢«å®³ã®ææ¸å¶åº¦ã®èªå®ããéããã«é²ãããã¨ãªã©ãå½ã«æ±ãã¾ããã æ°åã³ããã¦ã¤ã«ã¹ã®ã¯ã¯ãã³æ¥ç¨®ãããã£ã¦ã¯ãå¯åå¿ã§å¥åº·è¢«å®³ãåºããæ»äº¡ãããããå ´åãäºé²æ¥ç¨®æ³ä¸ã®ææ¸å¶åº¦ã®å¯¾è±¡ã¨ãªããæ¥ç¨®ã¨ã®å æé¢ä¿ãå¦å®ã§ããªãã¨å½ãèªå®ãã人ã«ã¯ãå»çè²»ãæ»äº¡ä¸æéãªã©ãæ¯çµ¦ããã¾ãã 9æ¥ã®ä¼è¦ã«ã¯ããã¨ã¨ã10æã«ã彿36æ³ã®å¤«ã2åç®ãæ¥ç¨®ãã3æ¥å¾ã«äº¡ããªããå æãææ¸ç³è«ãèªããããé ç°ç¦åããããåºå¸ãã¾ããã ãã®ä¸ã§é ç°ããã¯ã夫ã亡ããªã£ã¦ããã彿ãããªãã®ä¸ã«ããå¨ã¨ä¸ã®å3人ãè²ã¦ã¦ãããã®ããä¸å®ã®ä¸ã§æ¯æ¥ãéããã¦ãã¾ãããæ¥ç¨®ã®ä¸æ¢ãä¸çªã®æãã§ãããããã¦åãä¸å®ãæ±ãã¦ããå¤ãã®ãéºæã®è¿ éãªææ¸ãæã¿ã¾ããã¨è¨´ãã¾ããã ãã®ãã¨å£ä½ã¯
ãã®ç»åã大ããªãµã¤ãºã§è¦ã è³æ³¢æ¸¬å®ã«ãã£ã¦ããã§ã¤ã¹ããã¯ã使ç¨ããã¨ã³ã«ã¤ã³æç¨æã¨åãé åãæ´»æ§åãããã¨ã夿ãããç ç©¶ãçºè¡¨ããã®ã¯ãã¢ã¡ãªã«ãã«ãªãã©ã«ãã¢å·ç«å¤§å¦ã®ãªãã£ã«ã»ãã¥ã¬ã«ææã§ããã ãã¥ã¬ã«å士ã¯ã大å¦çã対象ã«ã¢ã³ã±ã¼ã調æ»ã¨å®é¨ãè¡ã£ãããã®çµæããã§ã¤ã¹ããã¯ã®ä¾å度ãé«ã被é¨è ã¯ãã³ã«ã¤ã³ä¸æ¯æ£è ã¨åçã®è³æ³¢ãã¿ã¼ã³ã示ããã¨ããã ãã¥ã¬ã«å士ã¯ãè¨20åã®å¤§å¦çã対象ã«ããã§ã¤ã¹ããã¯ã«é¢é£ããä¸å®ãé¢è±çç¶ãèè¤ãªã©ãèªèº«ã®âä¾åççãªâçç¶ãè©ä¾¡ãã¦ãããã¢ã³ã±ã¼ã調æ»ã宿½ããã ã¾ãããã¨åæã«ãã³ã³ãã¥ã¼ã¿ã¼ç»é¢ã«ç»åã表示ããããããã¿ã³ãæ¼ãã¦ãããã¨ããå®é¨ãè¡ã£ãã表示ãããç»åã«ã¯ãç¡ä½çºã«é¸ã°ããå¯¾ç §ç¾¤ã¨ãªãç»åã®ã»ãããã´ãã¢ã¤ã³ã³ãªã©ããã§ã¤ã¹ããã¯é¢é£ã®ãã®ãå«ã¾ãã¦ããããã®éãã¿ã³ãæ¼ãã¹ãã¼ãã¨è³ã®æ´»åãè¨é²ããã
ãã®ãã¼ã¸ã§ã¯ãè¬æ©æ³ï¼å»è¬åãå»çæ©å¨çã®å質ãæå¹æ§ãããã³å®å ¨æ§ã確ä¿ããããã®æ³å¾ï¼ã®åºæ¬çãªæ å ±ãããå ·ä½çãªè¦å¶å 容ãåºåã表示ã®ã«ã¼ã«ãéåæã®ç½°åã¾ã§ãå¹ åºããããã¯ã¹ãåãããããã¾ã¨ãã¦ãã¾ãã
2022å¹´08æ01æ¥19:26 ã«ãã´ãªï¼©ï½ãï¼¤ï½ ï½ ï½ ã¢ã»ãã¢ãããã§ã³ï¼æ¥æ¬åï¼ã«ããã¼ã«ï¼ã®å¦å©¦ããã¨ä¹³å¹¼å ã®æç¨ã¯ãåã©ãã®èªéçãç¥çµçºéã®åé¡ã®åå ã«ãªããã¨ããã³ã¹ã示ãããè«æãçºè¡¨ããã Iï½ãï¼¤ï½ ï½ ï½ããã®ãµã¤ããã https://indeep.jp/acetaminophen-and-children/ ä½ã§ãè¬ãè¬ã¨è¨ããã ãã®è¬ã®æ®ã©ã¯ç³æ²¹ããä½ããã¦ãããã ãï¼ ç³æ²¹ã飲ãã§ãããªãã¨æãã®ï¼ï¼ ã£ã¦è¨ããã§ããã©ãæãéããã°ã¾ãè¬ã«é ¼ãã£ã¦ å ¨ãçè§£ã§ããªãããã§ãã ï¼è»¢è¼éå§ï¼ ã¢ã»ãã¢ãããã§ã³ã®ä¹³å¹¼å ã¸ã®æå®³æ§ã¯æ³å以䏿è¿ãã«ããã¼ã«ãã¨ããè¨èãå ±éã§ããç®ã«ãã¾ãã è§£ç±é®çè¬ãã«ããã¼ã«ãåºè·èª¿æ´ã¸ æ°åã³ããã§éè¦æ¥å¢Â ï¼NHK 2022/07/29ï¼ æ°åã³ããã¦ã¤ã«ã¹ã®æ£è ã®æ¥å¢ã«ä¼´ã£ã¦å»çæ©é¢ã§å¦æ¹ãããè§£ç±é®çè¬ãã«ããã¼ã«ã
æ¯å¹´5æé ã«ãªãã¨ã ã«ããåºæ²¡ããæãå®¶ã 5æé ãã10æé ã¾ã§ã¯ãã ã«ãã®æçæãªã®ã§ããã®ææã«ãªãã¨ãã¤ã ã«ããåºæ²¡ãããã¨ãã©ãã©ãã£ã±ãªãã ã¡ãªã¿ã«æãå®¶ã®è¿ãã«ã¯æ£®ãããããããè¿æãããã¿ããªæ¯å¹´ã ã«ãã®ææã«æ¯ãã¦ãã¾ãï¼ç¬ï¼ ææã«ãªãã¨ãä»ã®å®¶ããæ²é³´ãèããããã¨ããã°ãã°ï¼ç¬ï¼ ã§ããæ£®ãè¿ããã仿¹ãªãã»ã»ã»ã¨è«¦ããããã«ã¯ããã¾ããã ãã¨ãã£ã¦ãå°ããåä¾ããããããããã飼ã£ã¦ããã¨ãå®¶ã®å¨ãã«æãããããå¸è²©ã®å¿é¿å¤ã使ãã®ãé¿ãããã¨ããã ãããªæã«ããããã«æ²¹ãã ã«ãããã«ãããã¨ããåãå°è³ã«æãã ç§ã¯ãã ã«ãã«æ©ããè¿æãããå·»ãè¾¼ãã§å®é¨ãã¦ã¿ã¾ããï¼ æ¬å½ã«ããã«æ²¹ã§ã ã«ããåºãªããªããªãã人ä½ã«ç¡å®³ã§ãããããé¦ãã»ã»ã»æé«ã§ãããã ä»åã¯ããããªããã«æ²¹ã§ã®ã ã«ã対çã«ã¤ãã¦ãç´¹ä»ãããã¾ããã ä»åã®å 容ã¯ãã¡ãï¼ ããã«æ²¹ã§ã®ã
以åã«ãç§ã "æ°åã³ããPCRæ¤æ»ã§é½æ§ã«ãªãã¦ã¤ã«ã¹" ã¨ãã¦æ°åã³ããã¦ã¤ã«ã¹ã®PCRæ¤æ»ã§ã¯ä»ã®é¢¨éªãèºçæ§çç¶ã示ãã¦ã¤ã«ã¹ãç´°èã«ã齿§åå¿ã示ããã¨ã¯ç¡ãã¨æ¸ãããããã¾ã ã«å¾ç大äºã«ãã®ãããæ ¹æ ã¨ãã¦PCRæ¤æ»ã§ä½ãæ¤åºãã¦ããã®ãåãããªãã¨è¨ã人ãããã®ã§ãä»åã¯ã·ã³ãã«ã«æ°åã³ããã¦ã¤ã«ã¹ã®PCRæ¤æ»è©¦è¬ã®æ¥æ¬èªã®èª¬ææ¸ãåãä¸ãããã å»è¬åå»çæ©å¨ç·åæ©æ§ã®HPã«ã¯æ¥æ¬ã§è²©å£²ä½¿ç¨ããã¦ããæ°åã³ããã¦ã¤ã«ã¹PCRæ¤æ»è©¦è¬ã®ä¸é¨ã®èª¬ææ¸ãå ¬éããã¦ããããã®åèª¬ææ¸ã®ä¸ã®äº¤å·®åå¿æ§ã®é ç®ã確èªããã°ãã©ã®ã¦ã¤ã«ã¹ãç´°èã«ã¯åå¿ãããããªãããä¸ç®çç¶ã§ããã â Loopampãæ°åã³ããã¦ã¤ã«ã¹2019(SARS-CoV-2)æ¤åºè©¦è¬ããã (å³å¯ã«ã¯PCRæ¤æ»ã§ã¯ãªãããPCRæ¤æ»ã¨åããéºä¼åæ¤æ»ãªã®ã§åãä¸ãã)ããã®èª¬ææ¸ã®ãæä½ä¸ã®æ³¨æãé ç®ï¼ã®å¦¨å®³ç©è³ª
ããã³ãã³=ä½ç«¹å®ãã¸ã§ã³ã½ã³è±é¦ç¸ã¯21æ¥ãæ°åã³ããã¦ã¤ã«ã¹ã¨ã®å ±ççãçºè¡¨ããã人å£ã®å¤§åãå ããã¤ã³ã°ã©ã³ãã§ææè ã®éé¢ãä¸è¦ã¨ããæ³çãªè¦å¶ãå ¨å»ãããæ°åã³ããã®éçåçãä½ãããã§ãã¤ã³ãã«ã¨ã³ã¶ã¨åæ§ã«æ±ã£ã¦é常ã®çæ´»ã«è¿ã¥ãããè¦å¶ã®å ¨é¢çãªè§£é¤ã¯ä¸»è¦å½ã§ã¯ã¯ããã¦ã¨ã¿ãããã24æ¥ã«ææè ã®éé¢ã®æ³çãªç¾©åããªããªãã宿çãªæ¥è§¦è ã®è¿½è·¡ãçµäºããã»ããææè ã¨æ¥è§¦ããå ´
åçå´åçã¯3æ¥ãç±³ãã¡ã¤ã¶ã¼ã¨ç±³ã¢ãã«ãè£½ã®æ°åã³ããã¦ã¤ã«ã¹ã¯ã¯ãã³æ¥ç¨®å¾ãè¥ãç·æ§ã§é常ããé«ãé »åº¦ã§å ±åããã¦ããå¿ççãå¿èçã®çç¶ã«ã¤ãã¦ãéå¸¸ã®æ³¨æåèµ·ãããé大ãªå¯åå¿ãã«è¦æåº¦ãå¼ãä¸ããå»å¸«ãã«å ±åã義åä»ãããã¨ã決ãããå¯åå¿ãåæãã¦ããåå´çã®å°éé¨ä¼ã§äºæ¿ãããã ã¢ãã«ãæ¥ç¨®ã§å¿ççã10ï½20ä»£ç·æ§ã®å²åé«ã 䏿¹ã§å¿ççãªã©ã¯æ°åã³ããææã®åä½µçã¨ãã¦èµ·ãããã¨ãããããã®é »åº¦ã¯ã¯ã¯ãã³æ¥ç¨®å¾ãããé«ããã¨ãåãã£ã¦ããããã®ããåå´çã¯ãæ¥ç¨®ã«ããã¡ãªããã®æ¹ãå¯åå¿ãªã©ã®ãã¡ãªããããã大ãããã¨ãã¦å¼ãç¶ãæ¥ç¨®ãæ¨å¥¨ããã
æ²ç¸çã¯15æ¥ãæ°åã³ããã¦ã¤ã«ã¹ã®æ°ããªææè ã0人ã ã£ãã¨çºè¡¨ããã1æ¥ã®ææè ãã¼ãã ã£ãã®ã¯2020å¹´7æ18æ¥ä»¥æ¥ãç´1å¹´4ã«æã¶ãã ãã²ã¨ç®ã§åãããæ²ç¸ã®ã³ããææç¶æ³ çå ã§ã¯20å¹´2æ14æ¥ã«åãã¦ææè ã確èªããããæµè¡ç¬¬5æ³¢ã®ãã¼ã¯ã¨ãªã£ã21å¹´8æ25æ¥ã«ã¯ã1æ¥ã¨ãã¦æå¤ã¨ãªã809äººã®ææã確èªããã人å£10ä¸äººå½ããã®æ°è¦ææè ã¯300人ã大ããè¶ ãããå ¨å½ã§ãææªã®ææç¶æ³ã¨ãªããå»çæ å¢ã屿©ã«ç´é¢ããã çµæ¸æ´»åãªã©ãå¶éãããç·æ¥äºæ 宣è¨ã¯è¨4ååºãããæ¥æ°ã¯è¨232æ¥ãç¹ã«4åç®ã®å®£è¨ã¯5æ23æ¥ãã9æ30æ¥ã¾ã§ã®4ã«æä»¥ä¸ã«åã³ã主è¦ç£æ¥ã®è¦³å ãä¸å¿ã«çå ã®çµæ¸ã«ææãä¸ããã 10ä¸äººãããå ¨å½8ä½ã«ããã®æ¥ã®çºè¡¨ã§ã¯ãã¯ã©ã¹ã¿ã¼ã¯æ°ãã«3ä¾ç¢ºèªãããã ç´è¿1é±éã®äººå£10ä¸äººå½ããã®æ°è¦ææè ã¯1.28ï¼åæ¥1.48ï¼ã§å ¨å½8ä½ã«ä¸ãã£ã
æ°åã³ããã¯ã¯ãã³ã®æ¥ç¨®ç¶æ³ãä¸å 管çããããã«å½ãå°å ¥ãããã¯ã¯ãã³æ¥ç¨®è¨é²ã·ã¹ãã ãï¼VRSï¼ã§ãåäººã®æ¥ç¨®è¨é²ã®ä¸é¨ã誤ã£ã¦ç»é²ããã¦ãããã¨ããã¸ã¿ã«åºãªã©ã¸ã®åæã§åãã£ããæ¥ç¨®ããã®ã«è¨â¦
65æ³ä»¥ä¸ã®æäººã«å¯¾ããèºççèã¯ã¯ãã³æ¥ç¨®ã«é¢ããèãæ¹ï¼ç¬¬3ç 2019-10-30ï¼ 65æ³ä»¥ä¸ã®æäººã«å¯¾ããèºççèã¯ã¯ãã³æ¥ç¨®ã«é¢ããèãæ¹ï¼2019å¹´ï½2023å¹´ã®æ¥ç¨®ï¼ ï¼å å®¹ï¼ 1ï¼ã¯ããã« 2ï¼PPSV23ã®å®ææ¥ç¨®ã«ã¤ã㦠3ï¼æäººã«ãããPCV13ã®ä½ç½®ã¥ã 4ï¼PCV13-PPSV23é£ç¶æ¥ç¨®ã®èãæ¹ 5ï¼ååå§å¡ä¼ã®è¦è§£ 6ï¼PPSV23ã¨PCV13ã®ä½µç¨æ¥ç¨®æã®æ¥ç¨®ééã«é¢ããèãæ¹ 7ï¼å®ææ¥ç¨®ã¨ãã¦ã®èºççèã¯ã¯ãã³æ¥ç¨®ã®èãæ¹ 8ï¼ãããã« è³æï¼ï¼æµ·å¤ã®äºé²æ¥ç¨®å¶åº¦ åèæç® ï¼ï¼ã¯ããã« 2014å¹´10æ1æ¥ãã23価èºççèè¢èããªãµãã«ã©ã¤ãã¯ã¯ãã³(PPSV23)ã®65æ³ä»¥ä¸ã®æäººã対象ã¨ããäºé²æ¥ç¨®æ³ã«åºã¥ã宿æ¥ç¨®ãéå§ããã65æ³ã®è åã³60æ³ä»¥ä¸65æ³æªæºã§å¿èãè èåã¯å¼å¸å¨ã®æ©è½ã«èªå·±ã®èº«è¾ºã®æ¥å¸¸ç活活åãæ¥µåº¦ã«å¶éãããç¨åº¦ã®é害ã
65æ³ã«ãªãã¨ãèªæ²»ä½ããèºççèã®ã¯ã¯ãã³ãæ¥ç¨®ããããã®æ¡å ãå±ãã¾ããããããäºé²æ¥ç¨®ã®æå¹æ§ãçè§£ãã¦ãã人ã¯ã¾ã å°ãªãããã§ãã¯ã¯ãã³æ¥ç¨®çã¯æãé«ã65æ³ã§ã4å²ç¨åº¦ã«ã¨ã©ã¾ã£ã¦ãã¾ãã ãåèè³æãå½ç«ææçç ç©¶æãèºççèã¯ã¯ãã³ã®ç¸å½å¹´é½¢å¥æ¥ç¨®è æ°ã¨æ¥ç¨®çã®æ¨ç§» https://www.niid.go.jp/niid/images/iasr/2018/07/461r10t01.gif ãã®è¨äºã§ã¯ãèºçã§äº¡ããªãæ¹ãè¦ããæ¹ãä¸äººã§ãæ¸ãããã¨ãã§ãããããèºççèã®æãããã¨ãªãäºé²æ¥ç¨®ãå¿ è¦ãªã®ãã説æãã¾ãã 1.èºççèã¯èºçã®åå 第ä¸ä½èºççèã¨ã¯ããã®åã®éãèºçãå¼ãèµ·ããå¼·åãªç´°èã§ããèºçãå¼ãèµ·ããç åä½ã¯ãã¤ã³ãã«ã¨ã³ã¶ã¦ã¤ã«ã¹ããã¤ã³ãã©ãºããªã©ã»ãã«ãããã¾ãããèºçã®åå 第ä¸ä½ã¯èºççèã§ãã å³ï¼å¸ä¸èºçã®ç å åºå ¸ï¼PfizerãHPï¼ãã¨
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}